Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02025816 · ClinicalTrials.gov registry record
RNAseq Analysis of Microbial Gene Expression in Necrotizing Soft Tissue Infections
A clinical trial, sponsored by Texas Tech University Health Sciences Center.
- Completed
- Registry status
- 35
- Enrollment target
NCT02025816: Completed study, sponsored by Texas Tech University Health Sciences Center.
NCT02025816 is a clinical trial that has completed, run by Texas Tech University Health Sciences Center. The registered enrollment target is 35 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02025816 has completed, sponsored by Texas Tech University Health Sciences Center.
- COMPLETED
- Registry status
- 35 participants
- Enrollment target
Study Summary
Hypothesis: We hypothesize that RNAseq will allow us to learn more about the causative agents of necrotizing soft tissue infections (NSTI) and risk factors involved in acquiring these devastating infections Tissue biopsies will be obtained from consented patients admitted with NSTI. Biopsies will be used for standard clinical analysis of bacterial species present or stored for later RNA sequencing. RNA sequencing will identify bacteria that are present within the infection site that may not be detected using standard culture techniques as well as reveal bacterial gene expression profiles within the NSTI site. Medical charts will also be reviewed for basic patient information as well as wound care management practices. We hope to identify bacterial species commonly present in these types of infections as well as risk factors predisposing individuals to NSTI's.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2013-12 |
| Est. Completion | 2019-06 |
What the finished NCT02025816 record still lists
NCT02025816 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 35 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02025816 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02025816 about?
NCT02025816 is a clinical study titled "RNAseq Analysis of Microbial Gene Expression in Necrotizing Soft Tissue Infections". Hypothesis: We hypothesize that RNAseq will allow us to learn more about the causative agents of necrotizing soft tissue infections (NSTI) and risk factors involved in acquiring these devastating infections Tissue biopsies will be obtained from consented patients admitted with NSTI. Biopsies will b...
What is the current status of trial NCT02025816?
This trial is currently completed. The enrollment target is 35 participants. The study started on 2013-12. Estimated completion is 2019-06.
Who is sponsoring clinical trial NCT02025816?
This trial is sponsored by Texas Tech University Health Sciences Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia